Why the study?
Does a multidisciplinary system-level quality improvement intervention (EMR redesign, provider education, and pharmacist verification) improve guideline-concordant inpatient dapagliflozin 10-mg prescribing in hospitalized patients with HFrEF?
Observational (n=149)
No
Does a multidisciplinary system-level quality improvement intervention (EMR redesign, provider education, and pharmacist verification) improve guideline-concordant inpatient dapagliflozin 10-mg prescribing in hospitalized patients with HFrEF?
System-level EMR workflow redesign combined with provider education and pharmacist verification improved guideline-concordant 10-mg dapagliflozin prescribing and reduced inappropriate 5-mg dosing among hospitalized HFrEF patients.
Answers are grounded in this paper and cite their sources.
Supports implementing multidisciplinary QI bundles to boost guideline-concordant dapagliflozin dosing in HFrEF; extends evidence for system-level interventions.
BACKGROUND: Despite strong evidence supporting dapagliflozin 10 mg daily for heart failure with reduced ejection fraction, variation in prescribing practices persists. PROJECT RATIONALE: Institutional review identified frequent use of non-guideline-supported dapagliflozin 5 mg dosing and demonstrated that inpatient dose selection strongly influenced discharge prescribing patterns. PROJECT SUMMARY: A multidisciplinary quality improvement intervention consisting of electronic medical record redesign, provider education, and pharmacist-led discharge verification was implemented on December 15, 2025. Among 124 preintervention patients, 83.9% received inpatient dapagliflozin 10 mg and 16.1% received 5 mg. Following intervention, guideline-concordant 10-mg prescribing increased to 92.0% and 5-mg prescribing decreased to 8.0%. Inpatient dose remained significantly associated with discharge prescribing behavior (P = 0.0467). TAKE-HOME MESSAGES: System-level workflow redesign improved adherence to guideline-concordant dapagliflozin prescribing and reduced non-evidence-based low-dose use. Similar implementation strategies may improve delivery of guideline-directed medical therapy in heart failure.
No takes yet. Share an insight, caveat, or question.
Karzoun et al. (2026) conducted an observational in Heart failure with reduced ejection fraction (HFrEF) (n=149). Multidisciplinary quality improvement intervention (EMR redesign, provider education, and pharmacist-led discharge verification) vs. Preintervention baseline standard prescribing workflow was evaluated on Guideline-concordant inpatient dapagliflozin 10-mg prescribing. A multidisciplinary quality improvement intervention increased guideline-concordant inpatient dapagliflozin 10-mg prescribing from 83.9% to 92.0% in hospitalized HFrEF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: